Skip to main content
    M

    Moleculin Biotech Inc (MBRX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $6.98
    -0.16 (-2.24%)

    Market Cap: $8.02M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Moleculin Biotech Inc (MBRX) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Moleculin Biotech (MBRX) has a latest price of $6.98 on Nov 17, 2026, 96.9% below its 52-week high of $227.05. Its price fell 96.8% over the past 12 months. The month-end price fell 100.0% over the 10 years through Oct 2026, a compound annual decline of 62.7%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $151,993.59 in Oct 2016 and its lowest $7.90 in Oct 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart MBRX with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for MBRX.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 39.0%, and over 6 months it fell 85.1%. The month-end price fell 99.8% over the 3 years through Oct 2026, a compound annual decline of 87.0%.

    PeriodChange
    1 month+31.7%
    3 months-39.0%
    6 months-85.1%
    12 months-96.8%
    12 months, with dividends-96.8%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-99.8%-87.0%
    5 years-100.0%-79.1%
    10 years-100.0%-62.7%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2019, when the price fell 12.0%, and its weakest was 2025, when it fell 92.2%.

    YearCloseChange
    2026 through Oct 2026$7.90-88.1%
    2025$66.20-92.2%
    2024$850.00-86.8%
    2023$6,434.78-19.0%
    2022$7,946.03-43.0%
    2021$13,943.03-61.1%
    2020$35,844.41-12.9%
    2019$41,146.19-12.0%
    2018$46,767.26-44.1%
    2017$83,641.44-18.4%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 27.6% below its 50-day average of $9.64 and 80.4% below its 200-day average of $35.55.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$6.98
    52-week high$227.05-96.9%
    52-week low$3.23+116.2%
    50-day average$9.64-27.6%
    200-day average$35.55-80.4%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 99.9%.

    MeasureValue
    1-year beta0.57
    Largest fall, 1 year-97.6%
    Largest fall, 3 years-99.9%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About MBRX

    What is MBRX's 1-year price change?

    Moleculin Biotech's price fell 96.8% over the past 12 months. With dividends included, the 12-month total return was -96.8%.

    What is MBRX's 5-year price change?

    Moleculin Biotech's month-end price fell 100.0% over the 5 years through Oct 2026, a compound annual decline of 79.1%. These figures leave out dividends.

    What is MBRX's 52-week high and low?

    Moleculin Biotech's 52-week high is $227.05 and its 52-week low is $3.23. Its latest price of $6.98 on Nov 17, 2026 is 96.9% below the high.

    What is MBRX's beta?

    Moleculin Biotech's 1-year beta against the S&P 500 is 0.57, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 97.6%.

    Is the MBRX chart free?

    Yes. Advanced Charting for MBRX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.